Indaptus Therapeutics Correlations

INDP Stock

USD 2.24 0.07 3.03%

The current 90-days correlation between Indaptus Therapeutics and Biomotion Sciences Ordinary is 0.37 (i.e., Weak diversification). The correlation of Indaptus Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.

Indaptus Therapeutics Correlation With Market

Modest diversification

The correlation between Indaptus Therapeutics and DJI is 0.25 (i.e., Modest diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Indaptus Therapeutics and DJI in the same portfolio, assuming nothing else is changed.

Build AI portfolio with Indaptus Stock

Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Indaptus Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in services.

To learn how to invest in Indaptus Stock, please use our How to Invest in Indaptus Therapeutics guide.

Moving together with Indaptus Stock

0.68

VRAX

Virax Biolabs Group

Pair Corr

Moving against Indaptus Stock

0.9	DNTH	Dianthus Therapeutics	Pair Corr
0.89	CMB	Cambium Bio	Pair Corr
0.77	688578	Shanghai Allist Phar	Pair Corr
0.73	DRTS	Alpha Tau Medical Earnings Call This Week	Pair Corr
0.66	DSGN	Design Therapeutics	Pair Corr
0.61	VCYT	Veracyte	Pair Corr
0.6	DMAC	DiaMedica Therapeutics	Pair Corr
0.53	RAC	Race Oncology	Pair Corr
0.52	VERA	Vera Therapeutics	Pair Corr
0.52	VIVS	VivoSim Labs, Symbol Change	Pair Corr
0.51	CDIOW	Cardio Diagnostics	Pair Corr
0.48	VANI	Vivani Medical	Pair Corr
0.47	DXB	Dimerix	Pair Corr
0.45	DRUG	Bright Minds Biosciences	Pair Corr
0.71	VTVT	vTv Therapeutics	Pair Corr
0.62	ENTO	Entero Therapeutics,	Pair Corr
0.58	ENGN	enGene Holdings Common	Pair Corr
0.55	VYGR	Voyager Therapeutics	Pair Corr
0.53	DYAI	Dyadic International	Pair Corr
0.5	VRDN	Viridian Therapeutics	Pair Corr
0.41	VTGN	VistaGen Therapeutics	Pair Corr
0.38	BSFA	BSF Enterprise Plc	Pair Corr

Related Correlations Analysis

	SLXN	REVB	PBM	NKGN	GTBP	ATXI	PTIX	SLRX	LIPO	AZTR
SLXN		0.97	-0.13	0.66	0.8	-0.76	0.36	0.71	0.46	0.8	SLXN
REVB	0.97		-0.09	0.76	0.76	-0.65	0.42	0.76	0.52	0.83	REVB
PBM	-0.13	-0.09		0.1	0.04	0.2	0.57	0.35	0.37	0.26	PBM
NKGN	0.66	0.76	0.1		0.55	-0.24	0.54	0.64	0.6	0.74	NKGN
GTBP	0.8	0.76	0.04	0.55		-0.62	0.3	0.6	0.47	0.65	GTBP
ATXI	-0.76	-0.65	0.2	-0.24	-0.62		-0.08	-0.4	-0.13	-0.49	ATXI
PTIX	0.36	0.42	0.57	0.54	0.3	-0.08		0.62	0.73	0.65	PTIX
SLRX	0.71	0.76	0.35	0.64	0.6	-0.4	0.62		0.61	0.88	SLRX
LIPO	0.46	0.52	0.37	0.6	0.47	-0.13	0.73	0.61		0.75	LIPO
AZTR	0.8	0.83	0.26	0.74	0.65	-0.49	0.65	0.88	0.75		AZTR
	SLXN	REVB	PBM	NKGN	GTBP	ATXI	PTIX	SLRX	LIPO	AZTR

Please upgrade your account to get full access to Macroaxis premium features

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

REVB	+ 0.97	SLXN
AZTR	+ 0.88	SLRX
AZTR	+ 0.83	REVB
GTBP	+ 0.8	SLXN
AZTR	+ 0.8	SLXN
NKGN	+ 0.76	REVB

High negative correlations

ATXI	- 0.76	SLXN
ATXI	- 0.65	REVB
ATXI	- 0.62	GTBP
AZTR	- 0.49	ATXI
SLRX	- 0.4	ATXI
ATXI	- 0.24	NKGN

Risk-Adjusted Indicators

There is a big difference between Indaptus Stock performing well and Indaptus Therapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Indaptus Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
SLXN	3.61	(1.51)	0.00	(0.61)	0.00	0.00	6.61	(11.26)	35.34
REVB	3.39	(1.63)	0.00	(1.21)	0.00	0.00	4.96	(8.33)	34.38
PBM	5.41	0.08	0.02	0.08	6.37	(6.29)	12.35	(8.67)	62.96
NKGN	28.14	11.77	0.30	1.10	15.71	(81.27)	100.00	(15.38)	445.00
GTBP	6.89	(0.76)	0.00	(0.28)	0.00	0.00	10.94	(18.80)	74.56
ATXI	4.94	0.78	0.09	(11.89)	5.71	(8.20)	16.44	(10.59)	44.74
PTIX	5.82	0.21	0.02	(0.21)	6.25	(7.30)	8.24	(10.94)	103.99
SLRX	6.00	(2.53)	0.00	(3.30)	0.00	0.00	10.05	(17.99)	66.07
LIPO	5.17	(0.41)	0.00	(0.14)	0.00	0.00	14.29	(11.67)	32.82
AZTR	4.83	(1.38)	0.00	(0.61)	0.00	0.00	9.18	(11.86)	51.47

Indaptus Therapeutics Corporate Management

MD MBA	Chief Officer	Profile
Jeffrey Meckler	CEO Director	Profile
Walt Esq	Chief Officer	Profile
Michael Newman	Chief Founder	Profile
Boyan MD	Chief Officer	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2025 Macroaxis LLC